Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 13/20 | 0.59 |
| ▸ | LPL | P06858 | 12/20 | 0.59 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA3 | P07451 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.40 |
| ▸ | CA6 | P23280 | 1/20 | 0.40 |
| ▸ | CA5A | P35218 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.40 |
| ▸ | F11 | P03951 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | SNCA | P37840 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | P4HB | P07237 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1963035 | 1.00 | LIPG (0.59) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL12890199 | 0.95 | LPL (0.51) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL18016692 | 0.95 | LPL (0.51) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL1505745 | 0.95 | LPL (0.51) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL16532853 | 0.94 | LIPG (0.71) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL15222374 | 0.93 | LIPG (0.67) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL14255583 | 0.90 | LIPG (0.49) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL4470995 | 0.89 | LIPG (0.71) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL16420981 | 0.89 | LIPG (0.57) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL21138915 | 0.89 | LIPG (0.57) | LIPGLPLCA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8632892-B2 | Organic electronic material, organic electronic device, and organic electroluminescent device | HITACHI CHEMICAL CO., LTD. (JP) | 2014-01-21 | — | — | US | disclosed |
| US-8632892-B2 | Organic electronic material, organic electronic device, and organic electroluminescent device | HITACHI CHEMICAL CO., LTD. (JP) | 2014-01-21 | — | — | US | disclosed |
| US-8632892-B2 | Organic electronic material, organic electronic device, and organic electroluminescent device | HITACHI CHEMICAL CO., LTD. (JP) | 2014-01-21 | — | — | US | disclosed |
| US-20090321723-A1 | ORGANIC ELECTRONIC MATERIAL, ORGANIC ELECTRONIC DEVICE, AND ORGANIC ELECTROLUMINESCENT DEVICE | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2009-12-31 | — | — | US | disclosed |
| US-20090321723-A1 | ORGANIC ELECTRONIC MATERIAL, ORGANIC ELECTRONIC DEVICE, AND ORGANIC ELECTROLUMINESCENT DEVICE | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2009-12-31 | — | — | US | disclosed |
| US-20090321723-A1 | ORGANIC ELECTRONIC MATERIAL, ORGANIC ELECTRONIC DEVICE, AND ORGANIC ELECTROLUMINESCENT DEVICE | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2009-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090321723-A1 | ORGANIC ELECTRONIC MATERIAL, ORGANIC ELECTRONIC DEVICE, AND ORGANIC ELECTROLUMINESCENT DEVICE | SLCO4C1, SLCO1A2, SLCO2A1 | LIPG 2279/4885LPL 2737/4885CA1 4659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.